Rivian CEO Calls 2027 an Inflection Year, Five Years After IPO
Rivian's CEO says the R2 SUV and driver-assistance software can turn the business around, while the stock sits far below its 2021 debut price and cash needs rise.
Strategy
CVS Health Plans to Separate Its Pharmacies From Aetna
CVS Health will break into two companies, one for its pharmacy chain and one for insurance and benefits. The plan comes under pressure from lawmakers and regulators over the size of US health groups.
Palantir Lifts Forecast After 96% Revenue Jump
Palantir reported third-quarter revenue of $2.3 billion and raised its yearly outlook, yet the shares slipped after hours. The report landed in a week of tech selloffs.
Gen Z Leans Toward Sedans as Ford and GM Weigh a Return
Surveys and insurance data show younger drivers leaning toward sedans. Ford and GM, which dropped them for SUVs and trucks, are reportedly exploring a return.
John Smedley Bets on Craft and New Ideas to Reverse a Sales Dip
The family-owned British knitwear maker lost money in its latest filed year. Its managing director says a turnaround is under way, built on new lines, partnerships and fresh equipment.
OpenAI Reportedly Trims Funding Target as S&P Sours on Meta
OpenAI reportedly cut its fundraising goal to $20 billion, and S&P moved Meta's credit outlook to negative. Capital for big AI spending looks tighter.